Episode 4 - Supportive Pharmacotherapy for Prevalent Co-morbidities

This activity is funded by Bayer AG and is not intended for a UK audience

Part IV of the course in pharmacotherapy in atrial fibrillation (AF) is exploring the fact that AF no longer is viewed as a solitary disease, but is strongly intertwined with a number of lifestyle conditions. The course will cover the relationships of AF to some of these conditions, and will provide evidence that lifestyle modifications per se can lead to better success rates in keeping patients in sinus rhythm whenever rhythm control strategy is chosen. Of course, this includes cardiovascular preventive pharmacotherapies for prevalent co-morbidities such as arterial hypertension, diabetes and heart failure.